References
Canaani, J., Beohou, E., Labopin, M., Ghavamzadeh, A., Beelen, D., Hamladji, R., Niederwieser, D., Volin, L., Markiewicz, M., Arnold, R., et al. (2019). Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis. J Intern Med 285, 407–418.
Chang, Y.J., Wang, Y., Liu, Y.R., Xu, L.P., Zhang, X.H., Chen, H., Chen, Y. H., Wang, F.R., Han, W., Sun, Y.Q., et al. (2017). Haploidentical allograft is superior to matched sibling donor allograft in eradicating pretransplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis. J Hematol Oncol 10, 134.
Kroger, N., Zabelina, T., Guardiola, P., Runde, V., Sierra, J., van Biezen, A., Niederwieser, D., Zander, A.R., and de Witte, T. (2002). Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 118, 67–73.
Itonaga, H., Aoki, K., Aoki, J., Ishikawa, T., Ishiyama, K., Uchida, N., Sakura, T., Ohashi, K., Kurokawa, M., Ozawa, Y., et al. (2018). Prognostic impact of donor source on allogeneic hematopoietic stem cell transplantation outcomes in adults with chronic myelomonocytic leukemia: a nationwide retrospective analysis in Japan. Biol Blood Marrow Transplant 24, 840–848.
Liu, Y., Huang, X., Fei, Q., Xu, L., Zhang, X., Liu, K., Chen, Y., Chen, H., and Wang, Y. (2019). Comparison analysis between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission. Sci China Life Sci 62, 691–697.
Liu, H.D., Ahn, K.W., Hu, Z.H., Hamadani, M., Nishihori, T., Wirk, B., Beitinjaneh, A., Rizzieri, D., Grunwald, M.R., Sabloff, M., et al. (2017). Allogeneic hematopoietic cell transplantation for adult chronic myelomonocytic leukemia. Biol Blood Marrow Transplant 23, 767–775.
Patnaik, M.M., and Tefferi, A. (2018). Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management. Am J Hematol 93, 824–840.
Sun, Y., Beohou, E., Labopin, M., Volin, L., Milpied, N., Yakoub-Agha, I., Piemontese, S., Polge, E., Houhou, M., Huang, X.J., et al. (2016). Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT data base. Haematologica 101, e352–e354.
Sun, Y.Q., Chang, Y.J., and Huang, X.J. (2018). Update on current research into haploidentical hematopoietic stem cell transplantation. Expert Rev Hematol 11, 273–284.
Wang, Y., Liu, Q.F., Xu, L.P., Liu, K.Y., Zhang, X.H., Ma, X., Fan, Z.P., Wu, D.P., and Huang, X.J. (2015). Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood 125, 3956–3962.
Wang, Y., Liu, Q.F., Xu, L.P., Liu, K.Y., Zhang, X.H., Ma, X., Wu, M.Q., Wu, D.P., and Huang, X.J. (2016). Haploidentical versus matchedsibling transplant in adults with Philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized study. Clin Cancer Res 22, 3467–3476.
Acknowledgements
This work was supported in part by the National Natural Science Foundation of China (81600103), National Natural Science Foundation of China (81530046), Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001), National Key Research and Development Program (2017YFA0104500), and Science and Technology Project of Guangdong Province of China (2016B030230003).
Author information
Authors and Affiliations
Corresponding author
Additional information
Compliance and ethics
The author(s) declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Sun, YQ., Zhao, C., Wang, Y. et al. Haploidentical stem cell transplantation in patients with chronic myelomonocytic leukemia. Sci. China Life Sci. 63, 1261–1264 (2020). https://doi.org/10.1007/s11427-019-1606-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-019-1606-3